631 related articles for article (PubMed ID: 12493344)
1. Pharmacologic perspective on the physiology of the lower urinary tract.
Andersson KE; Hedlund P
Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
[TBL] [Abstract][Full Text] [Related]
2. Overactive bladder--pharmacological aspects.
Andersson KE
Scand J Urol Nephrol Suppl; 2002; (210):72-81. PubMed ID: 12475021
[TBL] [Abstract][Full Text] [Related]
3. Bladder activation: afferent mechanisms.
Andersson KE
Urology; 2002 May; 59(5 Suppl 1):43-50. PubMed ID: 12007522
[TBL] [Abstract][Full Text] [Related]
4. Control of bladder function by peripheral nerves: avenues for novel drug targets.
Fry CH; Ikeda Y; Harvey R; Wu C; Sui GP
Urology; 2004 Mar; 63(3 Suppl 1):24-31. PubMed ID: 15013649
[TBL] [Abstract][Full Text] [Related]
5. Recent developments in the management of detrusor overactivity.
Kumar V; Templeman L; Chapple CR; Chess-Williams R
Curr Opin Urol; 2003 Jul; 13(4):285-91. PubMed ID: 12811292
[TBL] [Abstract][Full Text] [Related]
6. Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms.
Andersson KE
Int J Clin Pract Suppl; 2006 Dec; (151):8-16. PubMed ID: 17169005
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic agonists and antagonists: effects on the urinary bladder.
Sellers DJ; Chess-Williams R
Handb Exp Pharmacol; 2012; (208):375-400. PubMed ID: 22222707
[TBL] [Abstract][Full Text] [Related]
8. Purinergic P2X3 heteroreceptors enhance parasympathetic motor drive in isolated porcine detrusor, a reliable model for development of P2X selective blockers for detrusor hyperactivity.
D'Agostino G; Condino AM; Calvi V; Boschi F; Gioglio L; Barbieri A
Pharmacol Res; 2012 Jan; 65(1):129-36. PubMed ID: 22041665
[TBL] [Abstract][Full Text] [Related]
9. Advances in the pharmacological control of the bladder.
Andersson KE
Exp Physiol; 1999 Jan; 84(1):195-213. PubMed ID: 10081718
[TBL] [Abstract][Full Text] [Related]
10. Afferent mechanism in the urinary tract.
Kanai AJ
Handb Exp Pharmacol; 2011; (202):171-205. PubMed ID: 21290227
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase and the lower urinary tract: possible implications for physiology and pathophysiology.
Andersson KE; Persson K
Scand J Urol Nephrol Suppl; 1995; 175():43-53. PubMed ID: 8771275
[TBL] [Abstract][Full Text] [Related]
12. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability.
Jung SY; Fraser MO; Ozawa H; Yokoyama O; Yoshiyama M; De Groat WC; Chancellor MB
J Urol; 1999 Jul; 162(1):204-12. PubMed ID: 10379788
[TBL] [Abstract][Full Text] [Related]
13. Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats.
Zhang X; Igawa Y; Ishizuka O; Nishizawa O; Andersson KE
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):473-9. PubMed ID: 12700886
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional.
Chess-Williams R
Auton Autacoid Pharmacol; 2002 Jun; 22(3):133-45. PubMed ID: 12452898
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic modulation of urinary bladder function: multiple targets at multiple levels.
Michel MC
Annu Rev Pharmacol Toxicol; 2015; 55():269-87. PubMed ID: 25251997
[TBL] [Abstract][Full Text] [Related]
16. Purinoceptors as therapeutic targets for lower urinary tract dysfunction.
Ford AP; Gever JR; Nunn PA; Zhong Y; Cefalu JS; Dillon MP; Cockayne DA
Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S132-43. PubMed ID: 16465177
[TBL] [Abstract][Full Text] [Related]
17. The overactive bladder: pharmacologic basis of drug treatment.
Andersson KE
Urology; 1997 Dec; 50(6A Suppl):74-84; discussion 85-9. PubMed ID: 9426756
[TBL] [Abstract][Full Text] [Related]
18. Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers.
Lawrence GW; Aoki KR; Dolly JO
J Pharmacol Exp Ther; 2010 Sep; 334(3):1080-6. PubMed ID: 20576797
[TBL] [Abstract][Full Text] [Related]
19. Purinergic signalling in the urinary bladder.
Andersson KE
Auton Neurosci; 2015 Sep; 191():78-81. PubMed ID: 25979768
[TBL] [Abstract][Full Text] [Related]
20. Changes in cholinergic and purinergic neurotransmission in pathologic bladder of chronic spinal rabbit.
Yokota T; Yamaguchi O
J Urol; 1996 Nov; 156(5):1862-6. PubMed ID: 8863633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
